Alain Marty
25Patents
9h-index
39Co-inventors
75Inventor score
Filing activity: Jul 28, 1994 → Dec 22, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5725579A | Process for treating bone tissue and corresponding implantable biomaterials | Emerging Cross-Sectional Technologies | 102 | Expired |
| US6217614A | Process for treating bone tissue and corresponding implantable biomaterials | Emerging Cross-Sectional Technologies | 39 | Expired |
| US10287561B2 | Polypeptide having a polyester degrading activity and uses thereof | Emerging Cross-Sectional Technologies | 18 | Active |
| US10767026B2 | Process for degrading plastic products | Emerging Cross-Sectional Technologies | 15 | Active |
| US10590401B2 | Esterases and uses thereof | Emerging Cross-Sectional Technologies | 14 | Active |
| US10584320B2 | Esterases and uses thereof | Emerging Cross-Sectional Technologies | 13 | Active |
| US11072784B2 | Esterases and uses thereof | Emerging Cross-Sectional Technologies | 13 | Active |
| US10717996B2 | Recombinant yeast cells producing polylactic acid and uses thereof | Chemistry; Metallurgy | 13 | Active |
| US10829754B2 | Plastic degrading proteases | Emerging Cross-Sectional Technologies | 13 | Active |
| US5522228A | Production of cold by adsorption/desorption of carbon dioxide | Mechanical Engineering; Lighting; Heating | 7 | Expired |
| US11414651B2 | Esterases and uses thereof | Emerging Cross-Sectional Technologies | 6 | Active |
| US8034377B2 | DHA esters and use thereof in treatment and prevention of cardiovascular disease | Chemistry; Metallurgy | 5 | Active |
| US11377533B2 | Process for degrading plastic products | Emerging Cross-Sectional Technologies | 5 | Active |
| US11345906B2 | Plastic degrading proteases | Emerging Cross-Sectional Technologies | 5 | Active |
| US11198767B2 | Process for preparing a biodegradable plastic composition | Emerging Cross-Sectional Technologies | 5 | Active |
| US11535832B2 | Esterases and uses thereof | Emerging Cross-Sectional Technologies | 4 | Active |
| US11926851B2 | Esterases and uses thereof | Emerging Cross-Sectional Technologies | 2 | Active |
| US11851689B2 | Esterases and uses thereof | Emerging Cross-Sectional Technologies | 2 | Active |
| US11549105B2 | Proteases and uses thereof | Emerging Cross-Sectional Technologies | 2 | Active |
| US12098398B2 | Esterases and uses thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US8834867B2 | Method for producing lipase, transformed yarrowia lipolytica cell capable of producing said lipase and their uses | Human Necessities | 1 | Active |
| US12344714B2 | Esterases and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US8227479B2 | DHA esters and use thereof in treatment and prevention of cardiovascular disease | Chemistry; Metallurgy | 0 | Active |
| US8334130B2 | Method for producing lipase, transformed Yarrowia lipolytica cell capable of producing said lipase and their uses | Human Necessities | 0 | Active |
| US10415064B2 | Mutant yeasts capable of producing an unusual fatty acid | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.